| abstract |
This invention is aimed at providing a novel medicine for oculopathy, which has as an active component thereof a 5-HT 1A receptor ligand such as, for example, an alkylene dioxybenzene derivative represented by the following formula (I) ##STR1## wherein m represents an integer in the range of 2-5 and n an integer in the range of 1-3), a racemate thereof, or an acid addition salt thereof. |